| Sandra West, | |
|
3406 Glacier Hwy, Juneau, AK 99801-7251 | |
| (907) 463-3303 | |
| (907) 463-6858 |
| Full Name | Sandra West |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 3406 Glacier Hwy, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093476137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra West, 3406 Glacier Hwy, Juneau, AK 99801-7251 Ph: (907) 463-3303 | Sandra West, 3406 Glacier Hwy, Juneau, AK 99801-7251 Ph: (907) 463-3303 |
News Archive
Dr. David Fitzpatrick, Scientific Director and CEO at the Max Planck Florida Institute for Neuroscience, has been awarded a $2.4 million five-year grant from the National Eye Institute (NEI) of the National Institutes of Health (NIH) to study the functional organization and development of neural circuits in the cerebral cortex, specifically, in the area of brain responsible for processing visual information.
Boston-Researchers from Boston University School of Medicine (BUSM) have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model. The findings, reported in the American Journal of Drug and Alcohol Abuse, may lead to more effective treatments for alcoholism.
Coordinated Health, a top integrated healthcare delivery network across Pennsylvania and New Jersey, selected Sunrise Clinical Manager from Allscripts to help its clinicians improve care, better manage clinical information, and become more efficient.
Small pieces of nucleic acid, known as siRNAs (short interfering RNAs), can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials. Now, three new reports highlight the progress that researchers are making in developing broadly applicable, nanoparticle-enabled siRNA anticancer therapeutics.
Medical Facilities Corporation, today reported its financial results for the three- and nine-month periods ended September 30, 2010. All amounts are expressed in U.S. dollars unless indicated otherwise.
› Verified 2 days ago
Sanaz Ghorbanpoor, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 | |
Lila A Searer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Leslye Ann Galey, LPC Counselor Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8498 | |
Kayli Backes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Justin Parish, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 | |
Ms. Donna M Zahina, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5594 Aisek St., Juneau, AK 99801 Phone: 907-780-3048 Fax: 907-780-3053 | |
Dany Reyes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 |